AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms
This study aims to evaluate National Highly Specialized Care (NHV) for adults with severe and treatment-resistant self-harm or eating disorders in Sweden. The study examines patients' and their significant others' experiences of care, the feasibility of the treatment programs, and changes in patients' symptoms and functioning during and after treatment. Participants receive specialized inpatient care or a combination of inpatient and intensive outpatient treatment, based on their individual clinical needs. Treatment typically lasts approximately 12 weeks but may vary depending on the patient's circumstances. Additional interventions may be provided to address co-occurring psychiatric conditions. Information is collected through self-report questionnaires, qualitative interviews, and clinical records. Patients and their significant others are invited to complete assessments during treat
Sign in to get the eligibility rules as simple questions to take to your doctor.
AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy